| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  FreeOx Biotech Freeox Biotech is an innovative late-stage clinical company singularly focused on the discovery and development of Cerebrovascular Protective Therapeutics. A Phase III-ready investigational drug – Ox-01, the company’s lead asset – has been shown to be an effective emergency adjunct therapy to Mechanical Thrombectomy for the treatment of Acute Ischemic Stroke (AIS). Stroke, Oxidative stress, Neuroprotective therapies, Health research, Biotechnology, and Clinical research Type: | 0 | 0 | 0 | 3 |
 | Rethink Medical SL. Rethink Medical S.L. is a start-up company dedicated to the development of new medical devices in the nursing field. Rethink Medical is a Spanish startup company focused on developing innovative medical devices, mainly in the nursing field, based on real life experiences regarding both patient needs and common hospital procedures. Our first patented product is a urinary catheter We are working on other continence-related projects as well, improving healthcare processes and patient comfort due to the aging of the population and the increased need for these products. Type: | 0 | 0 | 0 | 5 |
 | Probably Genetic Helping people with rare genetic diseases get answers. Probably Genetic helps undiagnosed rare disease patients find answers to their symptoms in a matter of weeks. There are over 400 million people worldwide that have a rare disease — more than cancer and HIV patients combined. Half of those patients are currently undiagnosed and half of them are children, and it takes 5-7 years on average for these patients to get a diagnosis. With our system, patients can get answers in a matter of weeks. Our online Symptom Checker identifies rare disease patients using state-of-the-art machine learning models, gets them tested … Type: | 0 | 0 | 0 | 21 |
 | Spindiag GmbH The infection control solution. Spindiag is a spin-off of Hahn-Schickard, one of the world’s leading research institutions for microsystems technology. Based on its patented microfluidic platform “LabDisk”, Spindiag develops an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable screening for respiratory pathogens such as SARS-CoV-2 or drug-resistant pathogens. Behavior guidelines: https://www.spindiag.de/social-media-netiquette/ Impressum Spindiag GmbH Daniel Mark Engesserstr. 4a 79108 Freiburg Germany Email: info@spindiag.de Phone: +49 761 203 73246 Amtsgericht Freiburg im Breisgau HRB 714527 Tax ID number: DE305897842 point-of-care testing and in-vitro diagnostics Type: | 0 | 0 | 0 | 18 |
 | ANGANY Immunity Humanité ANGANY is an emerging, private pharmaceutical company, based in Quebec City, Canada. ANGANY has tackled the specific challenges of allergy to invent first-in class pharmaceuticals. ANGANY has developed an exclusive vaccine platform based on synthetic biology: the eBioparticle TM self-adjuvant vector. ANGANY also produces high quality, high purity allergens for diagnostic purposes. Finally, ANGANY has developed a flexible, fast and highly scalable 3rd generation plant production platform. ANGANY's vaccine approach opens the door to applications in cancer, infectious, autoimmune diseases and others. ANGANY is a Franco-Canadian collaboration led by Louis-Philippe Vézina, a renowned pharmaceutical entrepreneur. allergenes recombinants, immunotherapy, … Type: | 0 | 0 | 0 | 18 |
 | APTEEUS Reconcile the time of Research with the one of Medecine APTEΞUS was created to provide clinicians and their patients suffering from orphan diseases, an innovative service of clinical biology that perfectly meets the emerging challenge of individualized medicine. APTEΞUS is engaged in patient-centric discovery of individualized treatments. Our technology allows the testing of thousands of molecules directly on primary cells sampled from patient with inborn error of metabolism. We can rapidly identify molecules that specifically correct the very molecular defect of the patient and give him a new opportunity to be cured. Type: | 0 | 0 | 0 | 10 |
 | First Wave BioPharma, Inc. Targeted, Non-Systemic Therapies for Gastrointestinal Diseases First Wave BioPharma, Inc. (formerly AzurRx BioPharma) is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. First Wave is currently advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two proprietary technologies – niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. First Wave’s niclosamide portfolio is led by three clinical programs: FW-COV, for COVID-19 gastrointestinal infections; FW-UP, for ulcerative proctitis … Type: | 1 | 0 | 1 | 12 |
 | Neurolixis New treatments for central nervous system disorders Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain. Neuroscience, Drug development, Rett Syndrome, Parkinson's disease, Biased agonism, and Orphan Drug Type: | 2 | 1 | 1 | 7 |
 | Adverum Biotechnologies We are on a global mission to establish gene therapy as a new standard of care for the leading causes of vision loss. Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its … Type: | 0 | 0 | 0 | 141 |
 | ZEDIRA GmbH Targeting Transglutaminase for Research & Medicine! ZED1227 First Tissue Transglutaminase Inhibitor in Clinical Trials! Zedira is specialist and global brand for transglutaminase. More than 200 specialty reagents for transglutaminase-related R&D. Researchers from academia and industry (including 12 of the top 15 big pharma companies) benefit from Zedira’s cutting edge products – and in an increasing manner – from customised services. Solutions for site specific labeling of proteins using transglutaminases form Zedira’s latest product field. Simply - "The Transglutaminase Company" and From bench to bedside Type: | 0 | 0 | 0 | 10 |
 | Precision BioSciences, Inc. Dedicated to Improving Life. Precision BioSciences, Inc. (Nasdaq: DTIL) is a pre-clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com. Gene Editing and Gene Therapy Type: | 2 | 1 | 1 | 124 |
 | OakLabs Scientific Reach New Heights With Your Biomarkers At OakLabs Scientific, we believe that each of us can live longer healthy. In a society where individual healthcare is increasingly challenging, we are pioneering ways to detect and avert disease before it occurs. Using our unique Artificial Intelligence algorithms and high-molecular-weight data, we are exploring individual health status in unprecedented depth. gene expression analysis, biotechnology, research, biomarkers, biomarker signatures, and companion diagnostics Type: | 0 | 0 | 0 | 10 |
 | ChromoTek new tools for better research #newtoolsforbetterresearch Part of Proteintech Group. ChromoTek pioneered the development and commercialization of alpaca Nanobodies. As a market and product leader for high quality and reliable Nanobody-based reagents, we assist scientists’ research world-wide. In addition, ChromoTek is a trusted service provider of custom-made Nanobodies for the pharmaceutical industry. Founded in 2008 ChromoTek has offices in Martinsried, Germany, and Hauppauge, NY. In contrast to traditional antibodies Nanobodies consist of only one single polypeptide chain; they are 15 kDa and the smallest antibodies known. ChromoTek GmbH, Affinity purification, Immunoprecipitation, Co-IP, Mass spectrometry, Ligand capture, Protein-protein interaction, GFP-Trap, Fluorescent … Type: | 0 | 0 | 0 | 16 |
 | Easy Medical Device Consulting Agency. Help you place your Compliant Medical Device on the market Easy Medical Device is a company that will support you to place your Medical Device on the market. With its network, the company is capable of finding you the right support you need to execute your tasks. If you have a project to develop or a problem to solve in terms of Quality and Regulatory Affairs, Easy Medical Device is your solution. We help companies that are bringing new devices on the market or companies that just need an upgrade of their system. We can also find you … Type: | 0 | 0 | 0 | 11 |
 |  NeoNeuro APTAMARKERS: Diagnostic fingerprints in blood for pathology detection NeoNeuro has developed a new scientific approach named Aptamarkers. In the past, biomarkers for the diagnosis of diseases have been developed based on an understanding of the disease and the effect of the disease on the regulation of proteins or metabolites. This approach is time-consuming and expensive as experimental hypothesis regarding the pathophysiology of the disease must be tested and progressively built upon. NeoNeuro set out to develop a new platform with the capacity to screen all epitopes that are present in blood. We are not only screening all molecules in blood … Type: | 1 | 1 | 0 | 2 |
 | VectorBuilder VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to … Type: | 1 | 1 | 0 | 73 |
 | DBS System Making blood samples travel - not people. DBS System is a medtech company located in the Swiss Health Valley providing advanced technology to collect and prepare blood samples in a less invasive, easier, cheaper, safer manner with precision and industry standard processes. We produce devices with patent pending microfluidic technology capable of plasma/serum extraction and volume control in a standardized and reliable format, dramatically increasing the potential of DBS samples in bioanalysis. The innovative HemaXis platform was developed to combine the power of labs to test and monitor health with people’s desire to stay well. HemaXis will help democratize blood … Type: | 1 | 0 | 1 | 6 |
 | Kiyatec Inc. Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and … Type: | 1 | 0 | 1 | 25 |
 | Q-linea At Q-linea, we design, develop, and deliver innovative technology to aid physicians and technicians to improve patient outcomes and save lives. We aim to vastly reduce the time to optimal therapy. Q-linea provides infectious disease diagnostics to create sustainable healthcare, now and in the future. For patients, physicians, and society. The company’s leading product, ASTar®, is a fully automated instrument for antimicrobial susceptibility testing, which produces a sensitivity profile from a positive blood culture within approximately six hours. This is 24 to 40 hours faster than current diagnostics. This contributes to reducing the use of broad-spectrum antibiotics. ASTar is CE-IVD … Type: | 0 | 0 | 0 | 120 |
 | Seres Therapeutics Leading the Microbiome revolution Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in … Type: | 3 | 1 | 1 | 329 |
 | MRM Health Redefining microbiome-based therapeutics MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition … Type: | 1 | 1 | 0 | 49 |
 | MV BioTherapeutics SA A Microbiota biotherapeutics and Vaccines company A Swiss Microbiota biotherapeutics and Vaccines company, a spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona. The patent protected Apy platform is a unique mechanism to generate protective immune response against enteric infections and to shape the intestinal microbiota in medical conditions with two applications: 1. ApyraVax® with the lead indication of Clostridium difficile infection 2. ApyraMed® with lead indications as enhancer in cancer immunotherapy and modulator of antibiotic-induced disbyosis. Research experiments and preclinical trials are performed in the research lab hosted at IRB. The company is looking for seed funding … Type: | 1 | 1 | 0 | 1 |
 | OPPILOTECH LTD Navigating Biology, Discovering Drugs Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We use the models to simulate biological processes in order to identify viable drug targets and discover new biology. The company is building a pipeline of first-in-class drug discovery programmes based on the identified targets. Type: | 1 | 1 | 0 | 10 |
 | PEPperPRINT GmbH The leading provider of high-density peptide microarrays for antibody validation, epitope mapping & antigen discovery. PEPperPRINT is an innovative biotech company from Heidelberg, Germany, and the leading provider of high density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses e.g. for epitope mapping, antibody biomarker discovery or the analysis of adverse immune effects. PEPperPRINT’s peptide microarrays and screening services have been used by … Type: | 0 | 0 | 0 | 23 |
 | GQ Bio Therapeutics High-Capacity Gene Therapy Vector Platform to Address Prevalent Diseases GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with a single vector, highly efficient gene delivery (high transduction efficiency), and large-scale manufacturability. Based on its HCAd vector platform, GQ Bio develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration. GQ Bio is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany and Liège, Belgium. biotechnology, gene therapy, osteoarthritis, drug development, human … Type: | 0 | 0 | 0 | 15 |
 | Lawford Davies & Co Life Sciences Lawyers in the UK and Germany We are a niche life sciences law firm with exceptional expertise in human tissue- and cell-based research, clinical care, and assisted reproduction. We advise established biotechnology companies as well as start-ups, fertility clinics, and biobanks. medical ethics, data protection, medical law, autonomy, biotechnology, clinical trials, consent, GDPR, Law, and Life sciences law Type: | 0 | 0 | 0 | 5 |
 | siTOOLs Biotech GmbH High Specificity Tools for RNAi, rRNA depletion & RNA Interactome Studies. Services: Making Sense of RNAi Screening Data We drive RNA research with tailored molecular tools. We are from Munich and provide researchers with highly complex & advanced genetic tools. Our core expertise is RNA interference, bioinformatics, and RNA research tools for RNA-Seq and Ribo-Seq. Distinguished by their exceptional targeting specificity and efficiency, our gene function analysis tools include - siPOOLTM for reliable gene silencing, raPOOLTM for targeted RNA affinity purification and riboPOOLTM for efficient ribosomal RNA depletion. Our technology combines high complexity oligo pooling (“Pack Hunter” approach), proprietary design … Type: | 0 | 0 | 0 | 10 |
 | CYTENA We make the development of modern therapies faster, safer, and more affordable. Join us to create the future of health! We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other … Type: | 0 | 0 | 0 | 77 |
 | Quantgene We are on a mission to KILL CANCER with Intelligent Genomics. Quantgene is on a mission to detect and end cancer early with Intelligent Genomics. By making genomics intelligent, we can now detect and eliminate cancer at the earliest stages. Universal early detection of cancer can reduce mortality rates up to 80% and end cancer as we know it. Cancer diagnostics, biotechnology, genomics, machine learning, oncology, precision medicine, cancer screening, deep sequencing, cancer, innovation, AI, and Cancer Detection Type: | 3 | 0 | 3 | 43 |
 | Starlab We believe in progress through science. Our solutions enable bright minds to change the world. We believe in progress through science. Our solutions enable bright minds to change the world. We are “Passionate for Science”. Since 1998. Our product portfolio specializes in the field of Liquid Handling Technology and laboratory products. Our product portfolio includes laboratory consumables such as pipette tips, single and multi-channel pipettes, cell culture, tubes, PCR consumables, nitrile and latex gloves, and benchtop equipment for general laboratory use. Our products and services are in daily use at research institutions in biological and medical institutes, universities and hospitals, … Type: | 1 | 1 | 0 | 280 |
 | OptimHal-ProtecSom Inspired by your breath® 💡 French designer of medical devices in the fields of asthma and allergy 📍 Normandy, France 🎓 Company certified ISO 13485:2016, medical device standard The Laboratory OptimHal-ProtecSom is a Norman research SME (Small and Medium-sized Businesses) which designs and manufactures in France medical devices for the lung deposition of medicine, asthma and allergy. The company, which dedicates a third of its resources directly to research, expands in part through an assertive politic of partnership: - Partnerships for the distribution of its devices, currently available in 30 countries through a network of 15 exclusive partners. - Partnerships … Type: | 2 | 2 | 0 | 28 |
 | Abtech Therapeutics Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible. Type: | 2 | 2 | 0 | 2 |
 | GROUPE JBT [Automatic translation follows] Let's build tomorrow's medical devices together JBT Group specializes in the design and manufacturing of molds and the injection of technical plastic parts for the industrial and medical sectors. A family business with 60 years of experience, leader in the segments of high-tech tooling and injected products for medical and pharmaceutical applications, the Group is in constant development. Employing 700 employees, the Group achieves a turnover of nearly 90 million euros. Managed from the historic site of Molinges, in the Jura, the strategic and development activities serve all 4 French sites and the 3 international sites. Today, … Type: | 1 | 1 | 0 | 72 |
 |  CellSine Discover your favorite frequencies to boost your drug discovery business CellSine provides devices and software that make advanced electrochemical impedance spectroscopy easily accessible to any microbiological researcher. It delivers a platform tool for a that enables a wide variety of biochemical studies. Biotechnology, Cell culture monitoring, Proteïn - Proteïn interactions, Suspension cultures, Receptor signaling, Biofilm maturation, and T lymphocyte activation Type: | 1 | 1 | 0 | 4 |
 | Integrated Micro-Chromatography Systems A leader in recombinant enzymes and automated micro-chromatography technologies About Integrated Micro-Chromatography Systems, Inc. At Integrated Micro-Chromatography Systems (IMCS), we strive to address the growing needs of clinical and research laboratories through advanced technologies that increase testing efficiency. IMCS products help to drive the future of precision medicine. We understand the importance of accuracy, which is why we are committed to delivering products that consistently provide fast, reliable results. Company History Integrated Micro-Chromatography Systems, Inc (IMCS) was founded in January 2013 by three scientists from the University of South Carolina. IMCS designs, develops, manufactures, and distributes next-generation recombinant proteins and … Type: | 1 | 0 | 1 | 29 |
 | SynTouch, Inc. We bring scientific certainty to decisions about product feel CREATING PRODUCTS THAT HUMANS PREFER TO TOUCH The SynTouch Toccare® Haptics Measurement System uses mathematical models based on proven haptics science to guide the design and manufacturing of products and materials that feel how humans prefer them to feel. The industries we serve include nonwoven fabrics and products, apparel, textiles, automotive, cosmetics, and consumer electronics. Everything the human finger can sense, the Toccare system can precisely and repeatedly quantify biomimetically. Designers and manufacturers use Toccare touch data to compare, test, communicate and optimize with both subtlety and accuracy the feel of … Type: | 0 | 0 | 0 | 12 |
 | Ossium Health The Greatest Wealth is Health Building a Healthier Future Our mission is to improve the health, vitality, and longevity of human beings through bioengineering. Who We Are At Ossium, we believe that science is humanity’s best weapon in the fight against disease, and we embrace the challenge of mobilizing the world’s healthcare ecosystem to win that fight. In pursuit of this goal, we empower our employees, maintain the highest standards of excellence, and are a force for good. PRINCIPLES The values we live by Impact We are mission-driven and results-oriented. We believe that a healthier world is a better one … Type: | 2 | 0 | 2 | 101 |
 | Koatum An innovative solution for medical implants Koatum is a MedTech startup that developed a medical implant coating technology for dental and orthopaedic implants. Koatum prevents inflammation and accelerates bone integration, for a faster, painless recovery. Technology provides opportunity to coat any materials which could not be coated with plasma sputtering due to the high temperatures involved. An inert first layer is ensuring perfect formation between implant and coating. Upper layers, made from hydroxyapatite without the intense heat used in plasma coating, remain bioactive and durable. Technology also provides the ability to implement drug delivery systems. With Koatum technology surgeon can … Type: | 0 | 0 | 0 | 3 |
 | Cyclica (acquired by Recursion, Nasdaq: RXRX) From molecule to medicine Unlocking the protein universe to discover the medicines of tomorrow Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter. Drug Development, Network Pharmacology, Drug Repositioning, Proteomics, Clinical Trials, Side Effects, Bioinformatics, Systems Biology, Drug Discovery, Artificial Intelligence, polypharmacology, medicines, Machine learning, pharmacology, pharmaceuticals, and bioinformatics Type: | 15 | 2 | 11 | 8 |
 | PDC*line Pharma A novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line) Founded in 2014 as a spin-off of the French Blood Bank (EFS), PDC*line Pharma is a French-Belgian biotech company that develops an innovative class of active immunotherapies to treat cancers. This cancer vaccine contains proprietary, potent, and scalable plasmacytoid dendritic cell line (PDC*line), whose remarkable characteristics make them excellently suited for immunotherapy. PDC*line is much more potent to prime and boost antitumor antigen, including neoantigens, specific cytotoxic T-cells than conventional vaccines and improves the response to checkpoint inhibitors. PDC*line offers unique advantages: - PDC*line … Type: | 9 | 1 | 4 | 37 |
 |  BioNTech SE Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. At BioNTech we understand that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. To pioneer the next generation of patient-specific immunotherapies, we have combined ground-breaking research with cutting-edge technologies to develop therapeutics for cancer and beyond. Our broad and synergistic suite of platforms, which include mRNA therapeutics, engineered cell therapies, antibodies and small molecule immunomodulators have been optimized for distinct modes of action, high precision targeting, high potency and efficacy. We are also developing … Type: | 38 | 17 | 8 | 4,420 |
 | Creativ-Ceutical Creativ-Ceutical provides strategic pricing, market access and health economics consulting in life sciences. We provide both the strategic advice and the technical services to deliver results that meet your expectations. We have broad experience in the areas of central nervous system (CNS), oncology, vaccines, metabolic/cardiovascular diseases, and rare diseases. These are complex and developing fields, where treatment paradigms are in constant evolution and where clinical and economic issues require rigorous analysis to determine the best therapeutic choices. This experience allows us to address the most complex challenges and to anticipate pricing and market access issues that will arise in other … Type: | 0 | 0 | 0 | 83 |
 | Venn Life Sciences - part of hVIVO plc Integrated Drug Development from Discovery to Market - Part of the hVIVO plc Venn Life Sciences - part of hVIVO plc is an Integrated Drug Development partner offering an unique combination of drug development consultancy, clinical trial design and execution, enabling us to create, plan and execute drug development programmes effectively for our customers. Venn’s capabilities and expertise includes: CMC, Non-Clinical, Clinical Development and Regulatory Affairs. With our independent position we can design an optimal program including risk assessment and mitigation, saving time and money whilst achieving project milestone objectives. Visit our website - www.vennlifesciences.com for more information. Drug Substance … Type: | 3 | 1 | 1 | 110 |
 | Wave Life Sciences Unlocking the broad potential of RNA medicines to transform human health Wave Life Sciences is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Our RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Our toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing us with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Our diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency … Type: | 5 | 3 | 3 | 309 |
 | Roka Furadada Smart active ingredients, safer sun exposure Catalonia Exponential Leader 2023 Roka Furadada’s mission is to reduce the incidence of skin cancer through research, development and production of active ingredients and medical devices, with high efficiency and low toxicologic and environmental impact OUR PURPOSE Roka Furadada wants to help to prevent and reduce the incidence of skin cancer. HOW ARE WE GOING TO DO IT? Developing the first intelligent ultra violet radiation filter: SMART UV, with new molecules that entail therapeutic activity to prevent and treat diseases associated with sun exposure. Cosmetics, Raw Materials , Ingredients, Cosmetic Ingredients, Sunscreen, Sun protection … Type: | 5 | 1 | 5 | 28 |
 | Tinnitracks Tinnitracks is a medical devices company based out of 30 Neuer Kamp, Hamburg-Sternschanze, Germany. Type: | 3 | 0 | 1 | N/A |
 | Five Alarm Bio Limited Boosting the body's ability to defend against the damage of aging Five Alarm Bio is a drug discovery company based in Cambridge, UK focusing on novel approaches to anti-aging, with broad potential therapeutic application. We are researching therapeutics that boost the body's ability to defend against the damage of aging. Type: | 0 | 0 | 0 | 4 |
 | Paleo Rewriting the story of meat. At Paleo, we are rewriting the story of meat. First, we hunted. Then, we bred. Now, we brew. Because we care. We care for the animals, for our next generations and for providing nutritious foods. We care for the planet and the legacy that we’ll pass on. That's why, to produce our animal heme proteins, we no longer use animals. Instead, we use yeast. At Paleo, we don’t need to breed, transport or slaughter livestock. We don’t use any antibiotics or hormones, and our product is free of GMOs. Our process of fermentation uses less … Type: | 3 | 1 | 3 | 33 |
 | Tân-Tân Foods [Automatic translation follows] The healthy and nutritious plant-based alternative Tân-Tân is a startup that campaigns for a healthier and plant-based food transition, through a range of medallions rich in protein and easy to cook. vegetarian, vegan, protein, and food transition Type: | 2 | 1 | 0 | 2 |
 | Robo Bionics A Hand for a Missing Hand with the Sense of Touch | National Startup Award 2021 | CSR Partnerships | Social Impact Robo Bionics has developed Grippy India’s Own NABL Lab Safety Tested and Certified, 3D printed Prosthetic hand with a sense of touch and multi-grip control. Designed, engineered, and proudly made in India, Grippy is a lightweight and affordable, battery-powered prosthesis now available in the Indian market for people with below elbow amputation age 15 years and above. Welcome to the future where we have made Bionics as simple as switching on a light bulb. Robo Bionics a Recognized … Type: | 6 | 0 | 6 | 3 |
 | NanoSpun Technologies We harness the power of biology to create revolutionary live-active cell-based products and solutions. NanoSpun is a global pioneer and frontrunner in the biotech, advanced materials and bioprinting spaces. We are leading the way to a whole new generation of cell-based products and solutions through the intelligent application of NanoSpun biological fabrics. No other company can do what we do. We encapsulate live and active biological cells and organisms, including bacteria, yeast, algae, plant cells, and mammalian to produce living tissues and fabrics with a wide application across many industries. Our current market focus is to revolutionize Skincare and Bioprocessing. … Type: | 0 | 0 | 0 | 10 |
 | Vytrus Biotech Natural Innovation for a Better Life. Applying the real power of plants to cosmetics through biotechnology We create natural active ingredients for skincare and haircare through innovative and sustainable biotechnology processes which obtain the real power of plants. Totipotent Cells Type: | 0 | 0 | 0 | 35 |
 | Limula Cell & Gene Therapy: Automated. Scalable. Accessible Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics. Bioproduction, Immunooncology, Cell therapy, Biotechnolgoy, Manufacturing, and CAR-T Type: | 1 | 1 | 0 | 17 |
 | FIRE1 Our purpose is to help millions of people living with heart failure to get their normal back. FIRE1 aims to improve patient quality of life, and patient outcomes, while lowering overall healthcare costs. Health Tech, Research & Development, Medical Devices, Software Engineering, and Clinical Type: | 1 | 1 | 0 | 68 |
 | AIOVA [Automatic translation follows] Vaccines for the future Based on innovative, patented technology, AIOVA aims to develop and market innovative vaccines, with high added value, to its pharmaceutical industrial clients. AIOVA is positioned in the fight against emerging or re-emerging and deadly pandemics of humans and animals, in a OneHealth approach, and in particular influenza (human and avian influenza), AIDS-type diseases, and, very recently , diseases caused by coronaviruses such as SARS-CoV-2, responsible for the current COVID-19 pandemic. The vaccines are designed using a patented DNA platform and have the properties of activating, in the vaccinated host, not only the production … Type: | 0 | 0 | 0 | 1 |
 | LABORATOIRES CRYOBEAUTY PHARMA [Automatic translation follows] Permanently eliminates brown spots in just one application! Our company specializes in the research, development and fine-tuning of medical devices in dermatology and dermo-cosmetics using cutting-edge technology, unique in the world. This is Cyto-Selective Cryotherapy. This breakthrough technology is patented. It benefits from numerous competitive barriers. Cyto-Selective Cryotherapy consists of acting on the skin with controlled and perfectly controlled cold to target, for the first time, only cells according to their sensitivity and viability to temperature variations with extreme precision without affecting all the other cells of the skin. skin. After many years of research, we have … Type: | 0 | 0 | 0 | 1 |
 | Evexta Bio Evexta Bio, formerly #Diaccurate, is a biopharmaceutical company exploring the new frontiers of #oncology in search of daring novel therapeutic approaches with the potential to save lives. Now in the clinic, the French biotech is currently developing two proprietary therapeutic assets with novel mechanisms of action across several indications: - Rupitasertib, formerly DIACC3010, an optimized S6K inhibitor with efficient AKT1/AKT3 control of feed-back loop. The oral anti-tumor agent is expected to enter phase 2/3 clinical trial in refractory ER+ HER2- metastatic breast cancer. - EVX020, formerly DIACC2020, an antibody-drug conjugate program using a sole-in-class KIF20A kinesin inhibitor as payload in … Type: | 4 | 0 | 4 | 14 |
 | Vetbiobank Leading Animal Cell Therapy - Improving Animal Healthcare. Vetbiobank is a biotech company specialized in veterinary regenerative medicine. For our customers and their animal companions (dogs, cats, horses), we are leveraging the unique biological potential of neonatal stem cells. Those stem cells deliver locally an appropriate set of bioactive messages to organise and promote the harmonious healing of injuries or dampen inflammatory chronic diseases. Funded in 2011, Vetbiobank has built its expertise on the experience of its founder, former expert in human cell therapy development, and cord blood derived stem cells. The mission of Vetbiobank is to provide veterinarians with … Type: | 1 | 1 | 0 | 10 |
 | Inventiva Pharma A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology. Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc Type: | 1 | 1 | 0 | 117 |
 | Cyprio Created in 2017, Cyprio is founded on ten years of research at the prestigious French institute for higher education in science and engineering, Ecole Supérieure de Physique et Chimie Industrielles de la ville de Paris (ESPCI Paris), with a strong expertise in the field of 3D cell culture, liver biology and drug development. This makes Cyprio the holder of a unique technology for fabrication of alginate liquid-core capsules containing 3D cellular models physiologically more relevant than traditional monolayer cell culture and compatible with high throughput screening applications. Our first product "HepatoPearl" has been validated as a beneficial in vitro liver … Type: | 2 | 1 | 2 | 11 |
 | NEOSTEO SIMPLE CREATIVE SOLUTIONS NEOSTEO is a smart innovative startup company specialized in the development, production and marketing of advanced implants solutions aimed to simplify orthopedic and trauma surgery. With over 15 years of experience and a state of the art production line, NEOSTEO’s team offer a comprehensive range of Knee Osteotomy Implants Solutions as well as a wide range of solutions for Forefoot surgery. The company's products are being distributed around Europe countries through its experimented global distribution network. NEOSTEO' Surgeons Advisory Board and engineers are committed to continuous research and development of new progressive products and technologies to support … Type: | 1 | 1 | 0 | 8 |
 | TERRAMIE [Automatic translation follows] Terramie is the specialist in the creation of therapeutic gardens and gardens of life, throughout France. Our advisors support healthcare establishments and their teams in creating tailor-made gardens, adapted to structures and pathologies. For a long-lasting and vibrant living space, we also support caregivers in training specific to the Garden tool. Because the garden is known for its benefits for everyone's well-being, the Terramie team is committed to sharing its knowledge, with the help of health professionals, always in accordance with our ethics. Our charter is based on: - Respect for the person - Adapting the garden … Type: | 1 | 0 | 0 | 1 |
 | SmartCatch For a reliable liquid biopsy accessible to everyone Precision medicine is the adaptation of a medical treatment to the exact molecular profile of each patient. More generally, it relies on the sophisticated analysis of circulating biomarkers (genetic, protein or cellular) in the blood flow of patients. SmartCatch arises from a research work initiated in 2012 by a team of multidisciplinary scientists from the Laboratory of Analysis and Architecture of Systems (LAAS, CNRS) and urologist surgeons of the IUCT-Oncopole and Toulouse hospital. The results of this work have been patented in February 2015. Carried by four of its inventors, SmartCatch was … Type: | 15 | 5 | 12 | 21 |
 | IHU LIRYC - Heart rhythm disease Institute 🔬 Liryc is an international research, clinical and teaching centre focusing on heart rhythm diseases. The Heart Rhythm Disease Institute (French: L'Institut des maladies du RYthme Cardiaque), is one of 6 French university hospital institutions created in 2011 as part of the investments in the future program ("Investissements d'avenir") to boost medical research and innovation. This institute, created by Professor Michel Haissaguerre along with cardiology teams of the University Hospital of Bordeaux, unites multiple specialties around cardiac electrophysiology from research on ionic channels (microgenerators producing electric flows in cells) to whole heart and patient care. LIRYC is a basic research, … Type: | 22 | 5 | 2 | 98 |
 | MDoloris Medical Systems Our technology help clinicians titrating analgesics to control surgical stress, and improve outcomes in both OR and ICU MDoloris Medical Systems is a young innovative start-up (ISO 9001 and ISO 13485 certified) created in June 2010 to leverage more than 23 years of academic research conducted at the University Hospital of Lille. Our mission is to provide clinicians with the means to efficiently, continuously and non-invasively asses patient pain and comfort. The goal is to personalize pain therapy, in order to avoid known adverse effects of over- or underdosage of those drugs. Our technology is ideal when patients are unable … Type: | 3 | 2 | 0 | 35 |
 | Kiro Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical … Tags: FrenchTech2030 Type: | 31 | 10 | 21 | 43 |
 | Alrena Technologies [Automatic translation follows] Teleconsult from white zones and medical deserts Alrena Technologies is a startup created in 2015 by an emergency doctor and a radiocommunications specialist, both concerned by the extension of medical deserts and the extent of digital deserts in France. Together, they have developed transmission solutions (mobile and secure) capable of covering the white areas of the territory. They then coupled portable and interoperable medical devices allowing para-clinical examinations to be carried out in the field. (the healthcare professional can use his or her own medical devices, as long as they are connectable). The results obtained are transmitted … Type: | 2 | 1 | 1 | 4 |
 | LYSOGENE Improve the lives of children with CNS diseases Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children. Founded in 2009 by Karen Aiach, whose own child was affected by a neurodegenerative disease, Lysogene is rooted in a deep and compassionate understanding of the impact these diseases have on patients and families. Karen’s personal experience fuels her determination to deliver real solutions that will improve patient outcomes and enhance quality of life for both patients and caregivers. Over the past 10 years, Lysogene has acquired deep experience in developing gene therapies—from early … Type: | 7 | 5 | 0 | 10 |
 | Remma [Automatic translation follows] 1st marketplace of used medical devices for professionals. 1st marketplace specializing in the sale and reconditioning of used medical devices for healthcare professionals. Type: | 1 | 0 | 0 | 7 |
 | CompagOs 3D in vitro bone models improving drug development and personalized medicine CompagOs, a Swiss spin-off from ETH Zürich, is advancing bone health by helping doctors to match the right patients with the right treatments and by helping researchers to translate research findings into clinical applications. Employing innovative 3D printing technology, we produce reliable and reproducible bone organoids, called Bon3OIDTM, that are mineralized and multicellular. Our goal is to drive advancements in the field of drug discovery, preclinical patient stratification, predictive diagnostics and personalized medicine. We are developing and offering Bon3OIDTM based products and services in the following areas: - Healthy … Type: | 0 | 0 | 0 | 4 |
 | Causeway Therapeutics Healthy Ageing Through Musculoskeletal Health Maintaining musculoskeletal health is the keystone of overall health as we get older. As we age our physical condition gradually deteriorates, leading to loss of strength, fitness and mobility. In most cases, this isn’t due to a simple decision to stop exercising. It is due to the breakdown of musculoskeletal function caused by disease. Musculoskeletal diseases such as osteoarthritis, tendinopathy and lower back pain are the primary causes of disability and early retirement in people over the age of 65. Currently, there are no approved disease-modifying drugs for these diseases, meaning that physical decline in … Type: | 2 | 0 | 1 | 7 |
 | ToxGenSolutions BV (TGS) Epigenetics-based diagnostics, prognostics and preventative therapeutics for high-impact chronic pathologies. ToxGenSolutions (TGS) applies toxicogenomic approaches on human health problems to provide the customer with epigenetic biomarker fingerprints for application in novel, more accurate, methods for the particular diagnosis of their need. TGS aims to develop novel and innovative epigenetic profiles hallmarking high-impact chronic and rare neurodevelopmental diseases to serve as early, preclinical, diagnostic verdicts of a disease. With the development of these novel tools, TGS aims to bridge the frequently large gap towards disease progression and therapeutic intervention. TGS provides novel epigenetic diagnostic methods for the early identification of pressing … Type: | 0 | 0 | 0 | 7 |
 | Sopharma We have an active and crucial role in raising standards of everyday life, in making people healthier, happier and safer. Sopharma PLC is one of the leading pharmaceuticals company in Bulgaria popular with manufacturing of high-quality medicines, modern businessethic and social responsibility. The highly technological process for development and production of our products is licensed according to the GPP - Good Production Practices. Type: | 0 | 0 | 0 | 612 |
 | HP Health Solutions Germany GmbH For more information, please visit www.gna-bio.com Laser PCR, Molecular Diagnostics, OEM, Molecular Technology, Biosecurity, Life Sciences, Food Safety, Nucleic Acid Amplification, Molecular Assays, Biotechnology, and Nanotechnology Type: | 0 | 0 | 0 | 23 |
 | IFPMA We represent the biopharmaceutical industry, partnering for global health progress and access to innovation. IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Biopharmaceuticals, Global Health Policy, Health Advocacy, Innovation, Medicines Quality, and Multistakholder Collaboration Type: | 33 | 12 | 25 | 66 |
 | PB&B Facial & Body Remodeling Technology for Medical Aesthetics PB&B Ltd. is a specialty Swiss Life Sciences company founded by bioengineers working with plastic surgeons & dermatologists to test and bring to market a new patented injectable technology for the remodeling of soft tissues of the face & body. PBB-002 enhances adipocytes' volume with fatty acids, as to provide natural & longer-term results with the highest level of safety. PB&B’s patented technology aims to transform a fast growing, multi-billion-dollar facial aging & body remodeling markets with the next generation of injectables in Medical Aesthetics. Aesthetics, Facial rejuvenation, Breast augmentation, Buttock augmentation, … Type: | 0 | 0 | 0 | 4 |
 | Piomic Medical Advanced wound care, made personal. There are about 50 million reported cases of patients suffering from hard-to-heal wounds, which has created a severe cost burden on global healthcare systems. Piomic developed an innovative medical device for the treatment of hard-to-heal wounds. The COMS® One Therapy System is a portable, hand-held device that incorporates the technologies for optical and magnetic stimulation, intended to promote wound healing in chronic leg and foot ulcers. It integrates smoothly into the patient’s healing journey with usage in all care environments. By developing a therapy that is safe and effective we hope to set a better … Type: | 0 | 0 | 0 | 16 |
 | Lymphatica Medtech Lymph Flow Matters Lymphatica develops medical devices for treatment of lymphatic diseases. Born in 2017 as a spin-off of 2 leading Swiss universities, our first product is intended to bring a terrific improvement in quality of life for lymphedema patients: LymphoDrain, the first implantable artificial lymphatic vessels, is a medical device intended to recirculate lymph inside the patient body, re-establishing the physiological fluid equilibrium. Type: | 1 | 0 | 0 | 12 |
 | VectivBio AG Life-Transforming Medicines for Patients Living with Serious Rare Diseases VectivBio AG is a clinical-stage biotechnology company focused on rare diseases with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer, Inc., for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and … Type: | 2 | 0 | 1 | 57 |
 | OxyNov Revolutionizing oxygen therapy with the FreeO2: a device that optimizes every stage of treatment during hospital care. We are and want to remain pioneers in offering powerful, innovative, and cutting-edge technologies to oxygen therapy care. Our mission is to overcome the current limitations of respiratory care and oxygen therapy to : - Improve the safety and quality of life of patients. - Optimize care in a context of increasing number of patients and of hospitalization cost control. Our flagship device, the FreeO2, an automated oxygen therapy system : - Adjusts oxygen flow to the patient's needs in real time, avoiding … Type: | 1 | 0 | 1 | 15 |
 | SeeO2 Energy Inc. Fuels and chemicals from CO2 SeeO2 Energy Inc. vision is to efficiently convert captured CO2 and/or water to fuels and chemicals using reversible solid oxide fuel cell technology. We provide our customers in the chemicals, metal processing, polymers, and utilities industries with a reliable, onsite and cost competitive industrial feedstocks for their products. ELECTROCHEMISTRY, Solid Oxide Fuel Cells, Solid Oxide Electrolysis Cells, Power to Gas, CO2 to Fuels, Reversible Fuel Cells, Electrolysers, Power to fuels, H2O electrolysis, CO2 electrolysis, and CO2 utilization Type: | 2 | 1 | 1 | 7 |
 | TRIANNI, Inc an AbCellera Company Exceptional Human Antibody Discovery Technology Trianni, Inc. is a biotech company specializing in human antibody discovery platform technology. We offer the leading in vivo platform enabling efficient discovery of fully-human monoclonal antibodies. The Trianni Mouse offers biologic drug discoverers a best-in-class solution for the isolation of therapeutic antibody candidates. Benefits over older conventional mouse immunization + humanization approaches include superior lead panels with respect to potency and diversity along with speed to the clinic and lower operating costs. We aim to make Trianni’s premium technology available to any Pharma or Biotech company engaged in antibody discovery by offering flexible licenses … Type: | 0 | 0 | 0 | 1 |
 | Skye Bioscience Inc. Unlocking the pharmaceutical potential of cannabinoids Skye Bioscience (OTC:SKYE) is focused on unlocking the pharmaceutical potential of the endocannabinoid system, initially through modulation of the CB1 receptor, to treat diseases with inflammatory, fibrotic, and metabolic processes. Type: | 2 | 1 | 1 | 13 |
 | PannTheraPi Development of innovative neurological therapeutics based on pannexin channels Panntherapi develops innovative drugs in Neurology by acting on a specific target, the activated pannexin 1 channel, aiming a better efficacy and tolerance than current drugs. Panntherapi offers breakthrough innovation for the two main issues in development of current drugs in neurological diseases: - Innovative target addressing the root cause of the diseases - Representative non-clinical model using among others ex vivo human brain tissues Biotech, Neurology, Epilepsy, and Deeptech Type: | 15 | 4 | 8 | 10 |
 | Galmed Pharmaceuticals Ltd. A clinical-stage drug development biopharmaceutical company for liver, metabolic & inflammatory diseases Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, AramcholTM, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide. Our corporate headquarters is located in Tel Aviv, Israel. For more information about Galmed, please visit our website at: www.galmedpharma.com Type: | 1 | 1 | 0 | 11 |
 | Arete Medical Technologies Our mission is to improve patient outcomes and healthcare efficiency, starting with chronic respiratory conditions. Chronic respiratory diseases reduce the quality of life of millions worldwide, and are a major cause of death. Health systems are increasingly strained. We believe improved care in the future can only come from more preventative and precision care. We apply advances in digital technologies and medical devices to both improve care and health system efficiency. Type: | 5 | 1 | 3 | 4 |
 | ANS Biotech Our Services are as Unique as Your Discoveries ANS Biotech, a preclinical CRO dedicated to pain pharmacology, supports drug discovery and development efforts of companies involved in human and animal health, food and nutrition, by providing them with: • Clinically relevant in vivo models for successful R&D of innovative analgesics, especially in the field of inflammatory pain, neuropathic pain and visceral pain ; • Customized scientific studies meeting drug discovery and development objectives ; • Consulting activities. ANS Biotech also offers ALGOGramTM, a unique in vivo screening tool that provides a rapid and cost-effective means to systematically explore pain indications … Type: | 2 | 2 | 0 | 22 |
 | Abcell-bio Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for … Type: | 1 | 1 | 0 | 10 |
 | ASKORN MEDICAL Experts in medical devices design & development, quality assurance and regulatory affairs. Design, development and manufacturing of medical devices, from class I to class III. Consulting on Quality Assurance and Regulatory Affairs ISO 13485 : 2016 certified company by French Notified Body GMED. Registered with the FDA. Affaires réglementaires, Conseil en qualité, and Conception de dispositifs médicaux classe I à III Type: | 1 | 0 | 1 | 6 |
 | Personalized Stem Cells, Inc StemInsure®: Your Younger Cells For Life® Personalized Stem Cells, Inc. (PSC) is raising the standard of Stem Cell therapy. We are committed to providing high-quality stem cell processing services, as well as excellent technical, clinical, and regulatory support to physicians, clinical investigators, and patients. Type: | 0 | 0 | 0 | 5 |
 | Orphazyme A/S Our vision: To profoundly impact the lives of patients with orphan diseases and their families Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases. Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our … Type: | 2 | 0 | 1 | 14 |
 | novus med Surgical innovation, knowledge and reliability novus med are a UK medical device company specialising in the provision of Medical & Surgical innovation from around the globe. We seek out technological innovation that provides solutions to patients & clinicians that delivers sustainable value and cost savings to the healthcare system. To augment this, we pride ourselves in delivering unparalleled customer support. Products include : *Complete range of Laparoscopic Reusable, Resposable and Single-instruments *EMS Thulium Fibre Laser, LaserClast35 and LaserClast20 , Laser fibres *Hugemed - Single-Use Ureteroscope, Cystoscope, Choledochoscope * Full EndoUrology Portfolio - access sheaths, baskets, dilators, stents, irrigation *Mediflex range … Type: | 0 | 0 | 0 | 8 |
 | Medisolutions Medical devices for professionals Type: | 4 | 1 | 3 | 5 |
 | inven Some things cannot be comprised especially quality of life saving drugs, and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That`s why, we at Inven, are committed to apply science and our resources, for providing most innovative and quality products. We strive to provide access to safe, effective and affordable medicines to the people who need them. With a strong research oriented work culture, state-of-the-art production facility and end-to-end product development capabilities - Inven is recognized as a leading, ISO 9001-2000 and WHO GMP certified, IV fluid manufacturer in the international and domestic … Type: | 2 | 1 | 0 | 31 |
 | Carezzo Nutrition bv Carezzo heeft zich gespecialiseerd in het verrijken van dagelijkse voeding met eiwit, zoals brood, cake en fruitdrinks. Carezzo Nutrition markets protein enriched food & drinks, including bread and bakery, fruit juice and soups, fruit dairy and fruit ice cream. The assortment can replace regular food, so people can increase the protein intake by 50% without eating more. This new strategy of substitution of regular food is more effective in increasing the protein intake than the current practice of suppletion with in-between snacks or medical nutrition. Carezzo Nutrition was partner in a consortium Cater with Care, and developed in close cooperation … Type: | 0 | 0 | 0 | 6 |
 | Duplaco B.V. Reliable chlorella algae producer in the EU Duplaco, based in the Netherlands, reinvented farming to grow clean and rich Chlorella microalgae in a 100% closed system, without disturbing nature. These microalgae are packed with protein, fibers, vitamins, minerals and antioxidants. Big impact, tiny footprint. Microalgae, Biotechnology, Aquaculture, Food supplements, Feed, Tailor made, Fresh, Functional ingredient, Chlorella, Algae, Vegan, and Protein Type: | 4 | 0 | 4 | 26 |
 | De Novo Foodlabs Pioneering the future of nutrition. De Novo Foodlabs is a pioneering biotech start-up revolutionising the field of nutrition. Leveraging the power of microbial fermentation, the company creates innovative products that promote better health for both people and the planet. Food design, Product Development, Recombinant proteins, nutrition, health, and alternativeproteins Type: | 1 | 1 | 1 | 11 |
 | Avant Gratify Without Sacrifice: Technology for cleaner & more sustainable marine proteins Avant is the first cultivated fish company in Asia, with operations in Singapore and Hong Kong. Thanks to Avant's technology, we will be able to have fish meat without killing fish. Our cultivated fish products are more nutritious than conventionally produced fish, GMO-free, and pollutant-free. The pilot product focus of Avant's technology platform is fish and seafood tailored for the food culture of consumers in China and Asia. biotech, cultivated meat, and alternative protein Type: | 5 | 1 | 3 | 26 |
 | Change Foods (Re)creating dairy. Animal-free.TM (Re)creating dairy. Animal-free.TM Dairy, Cheese, Alternative Protein, #animalfree, #animalfreedairy, and #animalfreecheese Type: | 7 | 1 | 6 | 25 |
 | Shiru Shiru is creating the next generation of sustainable ingredients. We're powered by Flourish, our AI discovery engine. Shiru is an AI-enabled company developing performance ingredients for people and planet. Type: | 5 | 1 | 4 | 28 |
Startup